Ireland· IE-PA-PA1347/075/001

Olmesartan/Amlodipine Krka 20 mg/5 mg film-coated tablets

A olmesartan medoxomil und amlodipin product containing olmesartan medoxomil + amlodipine, registered in Ireland by KRKA, d.d., Novo mesto. The same ATC class is registered in 8 of our 19 countries.

ATC C09DB02

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olmesartan medoxomil + amlodipineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil und amlodipin is registered in 8 of 19 countries.

Countries holding a registration under ATC C09DB02 (olmesartan medoxomil und amlodipin), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
6 of them publish a price we can compare per daily dose

Search olmesartan medoxomil und amlodipin products by name

Olmesartan medoxomil und amlodipin · ATC C09DB02

8 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Ireland
Italyprice
Netherlands
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)

Active substance: Olmesartan medoxomil + Amlodipine
Manufacturer: KRKA, d.d., Novo mesto
Country: Ireland (IE)
ATC code: C09DB02
ATC class: Olmesartan medoxomil und Amlodipin
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA1347/075/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for olmesartan medoxomil und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olmesartan medoxomil und amlodipin against other medicines How interaction checks work

Olmesartan medoxomil und amlodipin · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil und amlodipin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Amelior, Olmesartan/Amlodipin 1a Pharma
Belgium · Forzaten, Forzaten®
Bulgaria · Amlodipine Besilate / Olmesartan Medoxomil Viatris Limited, Амлосарт
Cyprus · Alsamod, Comprelan
Czechia · Olmesartan/Amlodipin Zentiva, Olssa
Germany · Olmeamlo, Olmeamlodipin Puren
Estonia · Olmesartan Medoxomil/Amlodipine Accord, Olmesartan Medoxomil/Amlodipine Zentiva
Spain · Albis, Balzak
Finland · Olmesartan Medoxomil/Amlodipine Krka
France · Axeler, Sevikar
United Kingdom (Northern Ireland) · Olmesartan Medoxomil And Amlodipine Clydesdale Pharma, Olmesartan Medoxomil/Amlodipine Accord Healthcare
Greece · Comprelan, Olmedipin
Croatia · Olmita
Hungary · Duactan, Olmiza
Italy · Bivis, Giant
Lithuania · Olmesartan Medoxomil /Amlodipine Sandoz, Olmesartan Medoxomil/Amlodipine Accord
Luxembourg · Forzaten, Olmesartan/Amlodipine Eg
Latvia · Olmesartan Medoxomil/ Amlodipine Zentiva, Olssa
Malta · Konverge, Olmesartan Medoxomil/Amlodipine Ascend
Netherlands · Amlodipine Besylate/ Olmesartan Medoxomil Aurobindo, Amlodipine Besylate/Olmesartan Medoxomil Aurobindo
Poland · Elestar, Olmita
Portugal · Amlodipina + Olmesartan Medoxomilo Alter, Amlodipina + Olmesartan Medoxomilo Aurovitas
Romania · Almacor Duo, Inovum
Slovenia · Olectan, Olmita
Slovakia · Folgan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e165efed-21a8-4c10-9cc4-bcd27b0b204a
GET /v1/drugs/e165efed-21a8-4c10-9cc4-bcd27b0b204a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "C09DB",
    "C09DB02"
  ],
  "strength": null,
  "pa_number": "PA1347/075/001",
  "substances": [
    "Olmesartan medoxomil",
    "Amlodipine"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "18/08/2017",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about olmesartan medoxomil und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console